ȸ¿ø°¡ÀÔ | ¿¬¶ôó | »çÀÌÆ®¸Ê | English

      È¸»ç¼Ò°³ | ¸®Æ÷Æ® | Ä¿½ºÅÒ ¸®¼­Ä¡ | °í°´Áö¿ø


·Î±×ÀÎ

Ä«Å×°í¸®

À¯/¹«¼±Åë½Å

Àü±â/ÀüÀÚ

µðÁöÅбâ±â/¹Ìµð¾î/¹æ¼Û

Information Technology

¿¡³ÊÁö

»ý¸í°øÇÐ

È­ÇÐ/½Å¼ÒÀç

ÀÚµ¿Â÷

ȯ°æ

ÀϹݼҺñÀç

¸¶ÄÉÆÃ/±¤°í

±ÝÀ¶

°Ç¼³

±³Åë/¿î¼Û

¼ÒºñÀÚÁ¶»ç

¹æÀ§/Ç×°ø/¿ìÁÖ

½ÄÀ½·á

Áß°ø¾÷

±³À°

±â°è

¹«¿ª

½ºÆ÷Ã÷/·¹Àú

ÇØ¿î/Á¶¼±

ÆмÇ

Á¤ºÎ/Á¤Ã¥

°ø¿¹/±Í±Ý¼Ó

ÄÄÆÛ´Ï ÇÁ·ÎÆÄÀÏ

±âŸ»ê¾÷

 
ÇöÀçÀ§Ä¡ : HOME > ¸®Æ÷Æ® > »ý¸í°øÇÐ > Á¦¾à
Nanotechnology for Drug Delivery: Global Market for Nanocrystals
¹ßÇà»ç Cientifica

¹ßÇàÀÏ 2012-02
ºÐ·® 109 pages
¼­ºñ½ºÇüÅ Report
ÆǸŰ¡°Ý

ÀμâÇϱâ

Table of Contents

TABLE OF EXHIBITS

EXECUTIVE SUMMARY

CHAPTER 1 - INTRODUCTION

REPORT SCOPE
METHODOLOGY
- Procurement
- Calculation of CAGR
THE NANOSCALE
- Two biological examples that illustrate nanoscale:

CHAPTER 2 - NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE

OVERVIEW OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE
- Why is Nanotechnology A Critical Application for Medicine and Biomedicine?
- Why Nanotechnology Is Needed for Medicine and Biomedicine
WHAT ARE THE KEY DRIVERS FOR ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE?
- The Aim Of Drug Targeting
- Rapid Market Growth
- Market Drivers For Enhanced Drug Delivery
- Increasing Proportion of The Ageing Population
- Demand For More Affordable Health Care
- Public Health - Ending disease
- Demand for More Innovation
- Social responsibility
THE KEY APPLICATIONS OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE
- How Nanotechnology Can Benefit Drug Delivery
- Nanotechnology in Medical and Biomedical Diagnostics
- Nanotechnology in Regenerative Medicine and Tissue Engineering
- Other Applications For Nanomaterials In The Medical And Pharmaceutical Sector
PROMISING EXAMPLES OF NANOTECHNOLOGY ENABLED DRUG DELIVERY
- Case Study 1 - Magnetic Field Acts as 'Remote Control' to Deliver Nanomedicine
- Case Study 2 - Adaptive Micro and Nanoparticles: Temporal Control Over Carrier Properties to Facilitate Drug Delivery
- Case Study 3 - Fabrication of a Nanocarrier System Through Self-Assembly of Plasma Protein And Its Tumour Targeting
- Case Study 4 - IBM And The Institute of Bioengineering And Nanotechnology Find Breakthrough For MRSA

CHAPTER 3 - RISK & REGULATION

THREE KEY BARRIERS TO THE ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE
- Nanotoxicity, Nanopollution and Nanosafety
- Ethical Considerations Of Nanotherapies
- Delayed Nanoregulation
FIVE CURRENT & FUTURE CHALLENGES IN THE ADOPTION OF NANOTECHNOLOGY IN MEDICINE AND BIOMEDICINE
- Current & Future Challenges of Nanosafety And Risk Management
- Current & Future Challenges of Nanoregulation
- Current & Future Challenges for the Nanomedicine Industry
- Current & Future Challenges of Sustained Innovation
- Current & Future Challenges of Cooperation

CHAPTER 4 - MARKET FOR NANOCRYSTALS

GLOBAL NDD MARKET ANALYSIS: 2000-2010
GLOBAL NDD MARKET FORECAST: 2011-2021
DISCUSSION OF NANOPARTICLES AND NANOCRYSTALS
- Overview of The Key Nanotechnologies Used in Drug Delivery Sorted by Applications
- Nanopharmaceuticals
- Nanotechnology In Drug Delivery
- Nanobiotechnology In Drug Delivery
- Analytical Techniques For Nanoparticle Drug Delivery
- Properties
- Production of Nanoparticles
- Measuring Dispersion of Nanoparticles
- Characterisation of Delivery Systems
- What Can Nanoparticles do in Drug Delivery?
- Drug Nanocrystals: Nanosizing The Drugs
- Clinically Approved Nanocrystals-Based Drug Formulations With Presence on The Market
- Production methods
- Projected Product Pipeline For Nanocrystals-Based Drug Formulations In Drug Delivery Market
- Semapimod¢ç (cytokine, pharmasciences)
- Paxceed¢â
- Theralux¢â
- Nucryst¢ç
- iSPERSE¢â
ANALYSIS OF TAM FOR NANOCRYSTALS: 2000-2010
TAM FORECAST FOR NANOCRYSTALS: 2011-2021

APPENDIX

PUBLISHING ACTIVITY BY ORGANIZATION (2000-2010)


ȸ»ç¼Ò°³ | °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ | ÀÌ¿ë¾à°ü | ¹è¼Û/°áÁ¦¾È³» | ÀÌ¿ë¾È³»

¼­¿ï½Ã °­³²±¸ ³íÇöµ¿ 210-1 »ï¿øºôµù | ȸ»ç¸í : (ÁÖ)¿¤¾Ø¿¡Ä¡
´ëÇ¥ÀüÈ­ : 02-554-0001 / Æѽº : 02-3444-5501 / À̸ÞÀÏ : sales@landh.co.kr
Copyright ¨Ï 2008 LNH, Inc. All rights reserved.